Convergence of the two pandemics: metabolic syndrome and COVID-19 over last two years
has posed unprecedented challenges to individuals as well as healthcare systems …

Objective: The objective of this study was to appraise the interrelation between
overweight/obesity and the safety and efficacy of COVID-19 vaccination by synthesizing the …

Data evaluating effectiveness of XBB. 1.5-adapted vaccines against JN. 1-related endpoints
are scarce. This nationwide test-negative case-control study within the US Veterans Affairs …

Obesity is a recognized factor influencing immune function and infectious disease outcomes.
Characterization of the influence of obesity on SARS-CoV-2 humoral vaccine …

Abstract Background Infection with SARS-CoV-2 may perturb normal microbiota, leading to
secondary infections that can complicate the viral disease. The aim of this study was to …

Post-COVID-19 condition is recognized as a multifactorial disorder, with persistent presence
of viral antigens, discordant immunity, delayed viral clearance, and chronic inflammation …

Obesity is a known risk factor for severe respiratory tract infections. In this prospective study,
we assessed the impact of being obese or overweight on longitudinal SARS-CoV-2 humoral …

While obesity is a risk factor for post-acute sequelae of SARS-CoV-2 infection (PASC," long-
COVID"), the mechanism (s) underlying this phenomenon remains poorly understood. To …

Introduction In light of the public health burden of the COVID-19 pandemic, boosting the
safety and immunogenicity of COVID-19 vaccines is of great concern. Numerous Traditional …

The humoral response after vaccination was evaluated in 1248 individuals who received
different COVID-19 vaccine schedules. The study compared subjects primed with adenoviral …